An open-label trial of the PPARγ ligand rosiglitazone for active ulcerative colitis

American Journal of Gastroenterology

Volumn 96, Issue 12, 2001, Pages 3323-3328

  Lewis, James D ^a   Lichtenstein, Gary R ^a   Stein, Robert B ^a   Deren, Julius J ^a   Judge, Thomas A ^a   Fogt, Franz ^a   Furth, Emma E ^a   Demissie, E J ^a   Hurd, Linda B ^a   Su, Chinyu G ^a   Keilbaugh, Sue A ^a   Lazar, Mitchell A ^a   Wu, Gary D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOMODULATING AGENT; MERCAPTOPURINE; MESALAZINE; ROSIGLITAZONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON RESECTION; DISEASE ACTIVITY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMMUNOMODULATION; INFLAMMATION; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; COLONOSCOPY; FEMALE; HUMANS; LIGANDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 0035668404     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03895-3     Document Type: Article

References (21)

1. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee
2. Sulfasalazine revisited: A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis
3. The nuclear receptor superfamily: The second decade
4. The organization, promoter analysis, and expression of the human PPARgamma gene
5. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response
6. Peroxisome proliferator-activated receptor (PPAR) gamma: A new target for the treatment of inflammatory bowel disease
7. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial
8. 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada
9. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis
10. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study
11. Leukotrienes in ulcerative colitis: Results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591
12. Quantification of the placebo response in ulcerative colitis
13. Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis
14. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis
15. Hepatic failure in a patient taking rosiglitazone
16. Nephrotic syndrome after treatment with 5-aminosalicylic acid
17. Nephrotic syndrome associated with sulphasalazine
18. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: A randomized controlled trial
19. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase
20. Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury